Home LiteratureArticle Details
PMID: 22451663 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Plasminogen is a complement inhibitor.

The Journal of biological chemistry ·Vol. 287 ·No. 22 ·2012-05-25 ·Pages 18831-42

Barthel D, Schindler S, Zipfel PF

Abstract

Plasminogen is a 92-kDa single chain glycoprotein that circulates in plasma as a zymogen and when converted to proteolytically active plasmin dissolves preformed fibrin clots and extracellular matrix components. Here, we characterize the role of plasmin(ogen) in the complement cascade. Plasminogen binds the central complement protein C3, the C3 cleavage products C3b and C3d, and C5. Plasminogen binds to C3, C3b, C3d, and C5 via lysine residues, and the interaction is ionic strength-dependent. Plasminogen and Factor H bind C3b; however, the two proteins bind to different sites and do not compete for binding. Plasminogen affects complement action in multiple ways. Plasminogen enhanced Factor I-mediated C3b degradation in the presence of the cofactor Factor H. Plasminogen when activated to plasmin inhibited complement as demonstrated by hemolytic assays using either rabbit or sheep erythrocytes. Similarly, plasmin either in the fluid phase or attached to surfaces inhibited complement that was activated via the alternative and classical pathways and cleaved C3b to fragments of 68, 40, 30, and 17 kDa. The C3b fragments generated by plasmin differ in size from those generated by the complement protease Factor I, suggesting that plasmin-mediated C3b cleavage fragments lack effector function. Plasmin also cleaved C5 to products of 65, 50, 30, and 25 kDa. Thus, plasmin(ogen) regulates both complement and coagulation, the two central cascade systems of a vertebrate organism. This complement-inhibitory activity of plasmin provides a new explanation why pathogenic microbes utilize plasmin(ogen) for immune evasion and tissue penetration.

MeSH Terms
Complement Inactivating Agents/pharmacology Enzyme-Linked Immunosorbent Assay Humans Plasminogen/physiology Surface Plasmon Resonance
Chemicals
Complement Inactivating Agents Plasminogen
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Barthel Diana
Department of Infection Biology, Leibniz Institute for Natural Product Research and Infection Biology, Jena, Germany.
Schindler Susann
Zipfel Peter F
References (54)
54 references, click to expand
  1. Mechanism of complement resistance of pathogenic Borrelia burgdorferi isolates.
    Int Immunopharmacol. 2001 Mar;1(3):393-401 PMID: 11367524
  2. Generation of chemotactic activity in rabbit serum by plasminogen-streptokinase mixtures.
    J Exp Med. 1967 Jul 1;126(1):149-58 PMID: 4226164
  3. The inactivation of complement and its components by plasmin.
    J Exp Med. 1953 Apr;97(4):573-89 PMID: 13052820
  4. Complement and immune defense: from innate immunity to human diseases.
    Immunol Lett. 2009 Sep 22;126(1-2):1-7 PMID: 19616581
  5. Immune evasion of the human pathogen Pseudomonas aeruginosa: elongation factor Tuf is a factor H and plasminogen binding protein.
    J Immunol. 2007 Sep 1;179(5):2979-88 PMID: 17709513
  6. The interaction between pathogens and the host coagulation system.
    Physiology (Bethesda). 2006 Aug;21:281-8 PMID: 16868317
  7. A plasmin-split fragment of C'3 as a new chemotactic factor.
    J Exp Med. 1967 Aug 1;126(2):189-206 PMID: 4226271
  8. Complement and coagulation: causative considerations in contrast catastrophies.
    AJR Am J Roentgenol. 1979 Feb;132(2):171-6 PMID: 105577
  9. Complement regulator-acquiring surface protein 1 of Borrelia burgdorferi binds to human bone morphogenic protein 2, several extracellular matrix proteins, and plasminogen.
    J Infect Dis. 2010 Aug 15;202(3):490-8 PMID: 20565259
  10. Complement regulators and inhibitory proteins.
    Nat Rev Immunol. 2009 Oct;9(10):729-40 PMID: 19730437
  11. Molecular intercommunication between the complement and coagulation systems.
    J Immunol. 2010 Nov 1;185(9):5628-36 PMID: 20870944
  12. Immune evasion of Borrelia burgdorferi by acquisition of human complement regulators FHL-1/reconectin and Factor H.
    Eur J Immunol. 2001 Jun;31(6):1674-84 PMID: 11385611
  13. Amino-acid sequence of activation cleavage site in plasminogen: homology with "pro" part of prothrombin.
    Proc Natl Acad Sci U S A. 1975 Jul;72(7):2577-81 PMID: 1058475
  14. Factor H family proteins: on complement, microbes and human diseases.
    Biochem Soc Trans. 2002 Nov;30(Pt 6):971-8 PMID: 12440956
  15. Complement regulator Factor H mediates a two-step uptake of Streptococcus pneumoniae by human cells.
    J Biol Chem. 2010 Jul 23;285(30):23486-95 PMID: 20504767
  16. Complement evasion of pathogens: common strategies are shared by diverse organisms.
    Mol Immunol. 2007 Sep;44(16):3850-7 PMID: 17768102
  17. Fibrinolysis in normal plasma and blood: evidence for significant mechanisms independent of the plasminogen-plasmin system.
    Blood. 1976 Oct;48(4):531-45 PMID: 134751
  18. Fibrin and fibrinolysis in infection and host defense.
    J Thromb Haemost. 2007 Jul;5 Suppl 1:24-31 PMID: 17635705
  19. Binding of human complement regulators FHL-1 and factor H to CRASP-1 orthologs of Borrelia burgdorferi.
    Wien Klin Wochenschr. 2006 Nov;118(21-22):669-76 PMID: 17160605
  20. PAM, a novel plasminogen-binding protein from Streptococcus pyogenes.
    J Biol Chem. 1993 Dec 5;268(34):25417-24 PMID: 8244975
  21. Bidirectional relation between inflammation and coagulation.
    Circulation. 2004 Jun 8;109(22):2698-704 PMID: 15184294
  22. Interaction with C4b-binding protein contributes to nontypeable Haemophilus influenzae serum resistance.
    J Immunol. 2007 May 15;178(10):6359-66 PMID: 17475865
  23. Complement. Second of two parts.
    N Engl J Med. 2001 Apr 12;344(15):1140-4 PMID: 11297706
  24. Haemophilus influenzae interacts with the human complement inhibitor factor H.
    J Immunol. 2008 Jul 1;181(1):537-45 PMID: 18566420
  25. Thrombin generation and fibrin clot structure.
    Blood Rev. 2007 May;21(3):131-42 PMID: 17208341
  26. Interaction between the coagulation and complement system.
    Adv Exp Med Biol. 2008;632:71-9 PMID: 19025115
  27. Modulation of the classical pathway C3 convertase by plasma proteins C4 binding protein and C3b inactivator.
    Proc Natl Acad Sci U S A. 1979 Dec;76(12):6596-600 PMID: 293746
  28. Borrelia burgdorferi infection-associated surface proteins ErpP, ErpA, and ErpC bind human plasminogen.
    Infect Immun. 2009 Jan;77(1):300-6 PMID: 19001079
  29. Complement. First of two parts.
    N Engl J Med. 2001 Apr 5;344(14):1058-66 PMID: 11287977
  30. The alternative pathway of complement: a pattern recognition system.
    Adv Exp Med Biol. 2007;598:80-92 PMID: 17892206
  31. Characterization of plasmin(ogen) binding to Streptococcus pneumoniae.
    Indian J Med Res. 2004 May;119 Suppl:29-32 PMID: 15232158
  32. Factor H-related protein 1 (CFHR-1) inhibits complement C5 convertase activity and terminal complex formation.
    Blood. 2009 Sep 17;114(12):2439-47 PMID: 19528535
  33. Generation of C3d,g and C3d by urokinase-treated plasma in association with fibrinolysis.
    Complement. 1985;2(2-3):165-74 PMID: 2935360
  34. Factor H family proteins and human diseases.
    Trends Immunol. 2008 Aug;29(8):380-7 PMID: 18602340
  35. Functional characterization of Borrelia spielmanii outer surface proteins that interact with distinct members of the human factor H protein family and with plasminogen.
    Infect Immun. 2010 Jan;78(1):39-48 PMID: 19858303
  36. Plasminogen: a brief introduction into its biochemistry and function.
    Haemostasis. 1988;18 Suppl 1:7-13 PMID: 3280426
  37. Molecular mechanisms of fibrinolysis.
    Br J Haematol. 2005 May;129(3):307-21 PMID: 15842654
  38. The human complement system in thrombin-mediated platelet function.
    J Exp Med. 1978 Jun 1;147(6):1713-26 PMID: 681879
  39. Regulation and interactions in the activation of cell-associated plasminogen.
    Cell Mol Life Sci. 2004 Nov;61(22):2840-58 PMID: 15558213
  40. Gpm1p is a factor H-, FHL-1-, and plasminogen-binding surface protein of Candida albicans.
    J Biol Chem. 2007 Dec 28;282(52):37537-44 PMID: 17959597
  41. Secreted pH-regulated antigen 1 of Candida albicans blocks activation and conversion of complement C3.
    J Immunol. 2010 Aug 15;185(4):2164-73 PMID: 20644161
  42. Plasminogen activation in degradation and penetration of extracellular matrices and basement membranes by invasive bacteria.
    Methods. 2000 Jun;21(2):125-32 PMID: 10816373
  43. Haemophilus influenzae uses the surface protein E to acquire human plasminogen and to evade innate immunity.
    J Immunol. 2012 Jan 1;188(1):379-85 PMID: 22124123
  44. Characterization of the gene for human plasminogen, a key proenzyme in the fibrinolytic system.
    J Biol Chem. 1990 Apr 15;265(11):6104-11 PMID: 2318848
  45. Platelet mediated complement activation.
    Adv Exp Med Biol. 2008;632:81-91 PMID: 19025116
  46. The kringle domains of human plasminogen.
    Ciba Found Symp. 1997;212:46-60; discussion 60-5 PMID: 9524763
  47. Immune evasion of the human pathogenic yeast Candida albicans: Pra1 is a Factor H, FHL-1 and plasminogen binding surface protein.
    Mol Immunol. 2009 Dec;47(2-3):541-50 PMID: 19850343
  48. The complement fitness factor H: role in human diseases and for immune escape of pathogens, like pneumococci.
    Vaccine. 2008 Dec 30;26 Suppl 8:I67-74 PMID: 19388168
  49. The central role of the alternative complement pathway in human disease.
    J Immunol. 2006 Feb 1;176(3):1305-10 PMID: 16424154
  50. Bacterial metastasis: the host plasminogen system in bacterial invasion.
    Trends Microbiol. 2005 Feb;13(2):79-85 PMID: 15680767
  51. The Staphylococcus aureus protein Sbi acts as a complement inhibitor and forms a tripartite complex with host complement Factor H and C3b.
    PLoS Pathog. 2008 Dec;4(12):e1000250 PMID: 19112495
  52. An epitope of elongation factor Tu is widely distributed within the bacterial and archaeal domains.
    J Bacteriol. 1995 Jan;177(1):11-9 PMID: 7528200
  53. Thrombin generation, fibrin clot formation and hemostasis.
    Transfus Apher Sci. 2008 Feb;38(1):15-23 PMID: 18282807
  54. The human factor H-related protein 4 (FHR-4). A novel short consensus repeat-containing protein is associated with human triglyceride-rich lipoproteins.
    J Biol Chem. 1997 Feb 28;272(9):5627-34 PMID: 9038172
Article Info
Journal
The Journal of biological chemistry
Abbr.
J Biol Chem
ISSN
1083-351X
Published
2012-05-25
Epub
2012-00-27
Pages
18831-42
Language
English
Region
United States
NLM ID
2985121R
PMCID
PMC3365705
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com